View More View Less
  • 1 Corvinus University of Budapest Health Economics and Health Technology Assessment Research Centre Fővám tér 8 H-1089 Budapest Hungary
  • 2 Faculty of Medicine, Semmelweis University 2nd Department of Internal Medicine Budapest Hungary
  • 3 Faculty of Medicine, Semmelweis University 1st Department of Internal Medicine Budapest Hungary
Restricted access

First-line antihypertensive treatment’s drugs have to be able to decrease the cardiovascular morbidity and mortality. This kind of efficacy of thiazide-type diuretics has been published earlier in several studies. The efficacy of indapamide was investigated in several studies, but there is no analysis which is including all of the indapamide-studies. Objective: We conducted a meta-analysis of all relevant randomized-controlled-trials with indapamide. Efficacy of indapamide was analyzed in different cardiovascular and safety outcomes. Methods: We searched the MEDLINE database 1995–2006 for indapamide-trials. Only double-blind, parallel-group design trials were involved. Both the fixed effect model and the random effect model were used for data synthesis, results were probed with Mantel–Hanzel test and inverse variance test. Results: Data were combined from 9 trials that included 10,108 patients. Indapamide treatment of 48 patients with a history of stroke prevents one stroke (NNT = 47.8 95% CI: 29.6–126.6). Data from 5 trials including 7,085 patients show that indapamide is superior to placebo in reducing blood pressure, the differences are: 7.28 mm Hg (95% CI: 6.37–8.19) in systolic blood pressure and 3.50 mm Hg (95% CI: 2.99–4.01) in diastolic blood pressure. Data from 5 trials including 2,856 patients show that indapamide is superior to active controls in reducing systolic blood pressure, the difference is significant: 1.30 mm Hg (95% CI: 0.28–2.31). The difference in diastolic blood pressure was not significant. Data of 505 patients show that indapamide reduced left ventricular mass index significantly more than enalapril 20 mg, the difference is 6.50 g/m 2 (95% CI: 0.81–12.19). Data of 6,206 patients show that the frequency of adverse drug reaction is similar in the indapamide and placebo groups (RR = 0.97 95% CI: 0.76–1.22). Conclusions: Indapamide is efficacious in the prevention of further stroke, reduces effectively the blood pressure and the left ventricular mass index. Indapamide treatment is well tolerated.

  • Chobanian, A. V., Bakris, G. L., Black, H. R. et al.: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA, 2003, 289 , 2560–2572.

    Black H. R. , 'The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report ' (2003 ) 289 JAMA : 2560 -2572.

    • Search Google Scholar
  • Cifkova, R., Erdine, S., Fagard, R. et al.: Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J. Hypertens., 2003, 21 , 1779–1786.

    Fagard R. , 'Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines ' (2003 ) 21 J. Hypertens. : 1779 -1786.

    • Search Google Scholar
  • Magyar Hypertonia Társaság Szakmai Irányelvek Bizottsága: A hypertoniabetegség kezelésének szakmai irányelvei: a Magyar Hypertonia Társaság állásfoglalása, hetedik, módosított és kiegészített kiadás, 2005. november. ( Hungarian Society of Hypertension Guideline Committee: Clinical guidelines on treatment of high blood pressure: opinion of the Hungarian Society of Hypertension, 7th revised and complemented edition, November 2005.)(In Hungarian). Medicus Anonymus, 2006, 14 , 50–56.

    'A hypertoniabetegség kezelésének szakmai irányelvei: a Magyar Hypertonia Társaság állásfoglalása, hetedik, módosított és kiegészített kiadás, 2005. november. ' (2006 ) 14 Medicus Anonymus : 50 -56.

    • Search Google Scholar
  • Psaty, B. M., Lumley, T., Furberg, C. D. et al.: Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA, 2003, 289 , 2534–2544.

    Furberg C. D. , 'Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis ' (2003 ) 289 JAMA : 2534 -2544.

    • Search Google Scholar
  • Psaty, B. M., Lumley, T., Furberg, C. D.: Meta-analysis of health outcomes of chlorthalidone-based vs nonchlorthalidone-based low-dose diuretic therapies. JAMA, 2004, 292 , 43–44.

    Furberg C. D. , 'Meta-analysis of health outcomes of chlorthalidone-based vs nonchlorthalidone-based low-dose diuretic therapies ' (2004 ) 292 JAMA : 43 -44.

    • Search Google Scholar
  • Baguet, J. P., Robitail, S., Boyer, L. et al.: A meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure. Am. J. Cardiovasc. Drugs, 2005, 5 , 131–140.

    Boyer L. , 'A meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure ' (2005 ) 5 Am. J. Cardiovasc. Drugs : 131 -140.

    • Search Google Scholar
  • Robinson, D. M., Wellington, K.: Indapamide sustained release: a review of its use in the treatment of hypertension. Drugs, 2006, 66 , 257–271.

    Wellington K. , 'Indapamide sustained release: a review of its use in the treatment of hypertension ' (2006 ) 66 Drugs : 257 -271.

    • Search Google Scholar
  • Sassard, J., Bataillard, A., McIntyre, H.: An overview of the pharmacology and clinical efficacy of indapamide sustained release. Fundam. Clin. Pharmacol., 2005, 19 , 637–645.

    McIntyre H. , 'An overview of the pharmacology and clinical efficacy of indapamide sustained release ' (2005 ) 19 Fundam. Clin. Pharmacol. : 637 -645.

    • Search Google Scholar
  • Weidmann, P.: Metabolic profile of indapamide sustained-release in patients with hypertension: data from three randomised double-blind studies. Drug Saf., 2001, 24 , 1155–1165.

    Weidmann P. , 'Metabolic profile of indapamide sustained-release in patients with hypertension: data from three randomised double-blind studies ' (2001 ) 24 Drug Saf. : 1155 -1165.

    • Search Google Scholar
  • Higgins, J. P. T., Green, S.: Cochrane Handbook for Systematic Reviews of Interventions. John Wiley and Sons Ltd., Chichester, 2005.

    Green S. , '', in Cochrane Handbook for Systematic Reviews of Interventions , (2005 ) -.

  • Khan, K. S., ter Riet, G., Popay, J. et al.: Undertaking Systematic Reviews of Research on Effectiveness CRD Report Number 4 (2nd Edition), PHASE 5 Study quality assessment. 2001.

  • PATS Collaborating Group: Post-stroke antihypertensive treatment study. A preliminary result. Chin. Med. J. (Engl), 1995, 108 , 710–717.

    'Post-stroke antihypertensive treatment study. A preliminary result ' (1995 ) 108 Chin. Med. J. (Engl) : 710 -717.

    • Search Google Scholar
  • Ambrosioni, E., Safar, M., Degaute, J. P. et al.: Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group. J. Hypertens., 1998, 16 , 1677–1684.

    Degaute J. P. , 'Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group ' (1998 ) 16 J. Hypertens. : 1677 -1684.

    • Search Google Scholar
  • Emeriau, J. P., Knauf, H., Pujadas, J. O. et al.: A comparison of indapamide SR 1.5 mg with both amlodipine 5 mg and hydrochlorothiazide 25 mg in elderly hypertensive patients: a randomized double-blind controlled study. J. Hypertens., 2001, 19 , 343–350.

    Pujadas J. O. , 'A comparison of indapamide SR 1.5 mg with both amlodipine 5 mg and hydrochlorothiazide 25 mg in elderly hypertensive patients: a randomized double-blind controlled study ' (2001 ) 19 J. Hypertens. : 343 -350.

    • Search Google Scholar
  • Fiddes, R., Blumenthal, J., Dawson, J. E. et al.: Evaluation of indapamide 1.25 mg once daily in elderly patients with mild to moderate hypertension. J. Hum. Hypertens., 1997, 11 , 239–244.

    Dawson J. E. , 'Evaluation of indapamide 1.25 mg once daily in elderly patients with mild to moderate hypertension ' (1997 ) 11 J. Hum. Hypertens. : 239 -244.

    • Search Google Scholar
  • Gosse, P., Dubourg, O., Gueret, P.: Regression of left ventricular hypertrophy with echocardiography: some lessons from the LIVE study. J. Hypertens., 2003, 21 , 217–221.

    Gueret P. , 'Regression of left ventricular hypertrophy with echocardiography: some lessons from the LIVE study ' (2003 ) 21 J. Hypertens. : 217 -221.

    • Search Google Scholar
  • Kuo, S. W., Pei, D., Hung, Y. J. et al.: Effect of indapamide SR in the treatment of hypertensive patients with type 2 diabetes. Am. J. Hypertens., 2003, 16 , 623–628.

    Hung Y. J. , 'Effect of indapamide SR in the treatment of hypertensive patients with type 2 diabetes ' (2003 ) 16 Am. J. Hypertens. : 623 -628.

    • Search Google Scholar
  • London, G., Schmieder, R., Calvo, C. et al.: Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study. Am. J. Hypertens., 2006, 19 , 113–121.

    Calvo C. , 'Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study ' (2006 ) 19 Am. J. Hypertens. : 113 -121.

    • Search Google Scholar
  • Madkour, H., Gadallah, M., Riveline, B. et al.: Indapamide is superior to thiazide in the preservation of renal function in patients with renal insufficiency and systemic hypertension. Am. J. Cardiol., 1996, 77 , 23B–25B.

    Riveline B. , 'Indapamide is superior to thiazide in the preservation of renal function in patients with renal insufficiency and systemic hypertension ' (1996 ) 77 Am. J. Cardiol. : 23B -25B.

    • Search Google Scholar
  • Marre, M., Puig, J. G., Kokot, F. et al.: Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR Study. J. Hypertens., 2004, 22 , 1613–1622.

    Kokot F. , 'Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR Study ' (2004 ) 22 J. Hypertens. : 1613 -1622.

    • Search Google Scholar
  • Martins, M. C., Meyers, A. M., Whalley, N. A. et al.: Indapamide (Natrilix): the agent of choice in the treatment of recurrent renal calculi associated with idiopathic hypercalciuria. Br. J. Urol., 1996, 78 , 176–180.

    Whalley N. A. , 'Indapamide (Natrilix): the agent of choice in the treatment of recurrent renal calculi associated with idiopathic hypercalciuria ' (1996 ) 78 Br. J. Urol. : 176 -180.

    • Search Google Scholar
  • Molyneaux, L. M., Willey, K. A., Yue, D. K.: Indapamide is as effective as captopril in the control of microalbuminuria in diabetes. J. Cardiovasc. Pharmacol., 1996, 27 , 424–427.

    Yue D. K. , 'Indapamide is as effective as captopril in the control of microalbuminuria in diabetes ' (1996 ) 27 J. Cardiovasc. Pharmacol. : 424 -427.

    • Search Google Scholar
  • Rakić, D., Rumboldt, Z., Bagatin, J. et al.: Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study. Croat. Med. J., 2002, 43 , 672–679.

    Bagatin J. , 'Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study ' (2002 ) 43 Croat. Med. J. : 672 -679.

    • Search Google Scholar
  • Weidler, D., Jallad, N. S., Curry, C. et al.: Efficacious response with lower dose indapamide therapy in the treatment of elderly patients with mild to moderate hypertension. J. Clin. Pharmacol., 1995, 35 , 45–51.

    Curry C. , 'Efficacious response with lower dose indapamide therapy in the treatment of elderly patients with mild to moderate hypertension ' (1995 ) 35 J. Clin. Pharmacol. : 45 -51.

    • Search Google Scholar
  • Gosse, P., Sheridan, D. J., Zannad, F. et al.: Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study. J. Hypertens., 2000, 18 , 1465–1475.

    Zannad F. , 'Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study ' (2000 ) 18 J. Hypertens. : 1465 -1475.

    • Search Google Scholar